|
|
Webinar | Thermo Fisher Scientific Bioproduction | This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products. |
|
|
|
Webinar | Lonza | Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks. |
|
|
|
Video | Charter Medical | Learn how single-use manifolds can optimize your biomanufacturing processes, reducing time, space, and resources while increasing flexibility, product quality, and scalability. |
|
|
|
Video | Cytiva | Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, and gene editing. |
|
|
|
Video | Veristat, Inc. | In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial. |
|
|
|
Webinar | Contec, Inc. | Explore techniques like visual inspection and TOC sampling to assess surface residues as well as discover the benefits and challenges of these practical methods to achieve effective residue validation. |
|
|
|
Webinar | MilliporeSigma | Watch to explore two novel approaches that have been developed to overcome the limitation of a filter's viral retention performance in continuous processes. |
|
|
|
Video | 908 Devices | Discover a device that measures and controls critical bioprocess parameters in cell culture that uses an intuitive interface and Raman-based PAT solution for real-time monitoring and remote access. |
|
|
|
Webinar | Ecolab Life Sciences | Ensure your ATMP facility meets the latest Annex 1 standards for cleaning & disinfection residue control with the help of practical guidance and a case study detailed in this presentation. |
|
|
|
Video | Cell & Gene | Kimberly Benton, Ph.D., of Dark Horse Consulting, and Bambi Grilley, RPh, of Baylor College of Medicine and ISCT, discuss how scientific and manufacturing advances, along with evolving guidance, will shape the 2025 regulatory landscape for cell and gene therapy. |
|
|